These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37052853)

  • 1. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.
    Feng T; Li S; Zhao G; Li Q; Yuan H; Zhang J; Gu R; Ou D; Guo Y; Kou Q; Wang Q; Li K; Lin P
    Cell Oncol (Dordr); 2023 Oct; 46(5):1235-1252. PubMed ID: 37052853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth.
    Wang C; Tong Y; Wen Y; Cai J; Guo H; Huang L; Xu M; Feng M; Chen X; Zhang J; Wu H; Kong X; Xia Q
    Hepatology; 2018 Nov; 68(5):1833-1850. PubMed ID: 29663480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm associated antigen 4 promotes SREBP1-mediated de novo lipogenesis via interaction with lamin A/C and contributes to tumor progression in hepatocellular carcinoma.
    Liu T; Yu J; Ge C; Zhao F; Chen J; Miao C; Jin W; Zhou Q; Geng Q; Lin H; Tian H; Chen T; Xie H; Cui Y; Yao M; Xiao X; Li J; Li H
    Cancer Lett; 2022 Jun; 536():215642. PubMed ID: 35307486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
    Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
    Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
    Meng H; Shen M; Li J; Zhang R; Li X; Zhao L; Huang G; Liu J
    Eur J Pharmacol; 2021 Sep; 906():174280. PubMed ID: 34174265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D
    J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAMPT promotes the malignant progression of HBV-associated hepatocellular carcinoma through activation of SREBP1-mediated lipogenesis.
    He XL; Guo HJ; Lei YR; Li J; Li JY; Li MH; Li N; Wang F; Mo CF
    FASEB J; 2024 Jan; 38(2):e23444. PubMed ID: 38252081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma.
    Li Q; Yuan H; Zhao G; Ou D; Zhang J; Li L; Li S; Feng T; Gu R; Kou Q; Wang Q; Li S; Wang G; Zhao M; Yu H; Qu J; Lin P; Li K
    Biochem Pharmacol; 2024 Jul; 225():116251. PubMed ID: 38701867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
    Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
    J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation.
    Jin Q; Qi D; Zhang M; Qu H; Dong Y; Sun M; Quan C
    Cell Mol Biol Lett; 2024 Aug; 29(1):112. PubMed ID: 39169280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
    Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis.
    Wang Y; Zhang Y; Wang Z; Yu L; Chen K; Xie Y; Liu Y; Liang W; Zheng Y; Zhan Y; Ding Y
    Cell Death Discov; 2022 Oct; 8(1):431. PubMed ID: 36307402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
    Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
    Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
    Huang CJ; Zhang CY; Zhao YK; Wang D; Zhuang L; Qian L; Xie L; Zhu Y; Meng ZQ
    Am J Chin Med; 2023; 51(2):461-485. PubMed ID: 36655687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.